Nikita I. Grachev

Nikita I. Grachev

Auto-generated profile, based on publicly available information

Nikita I. Grachev

Pacific State Medical University; Primorsk Regional Clinical Hospital No. 1

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2025 in Journal of Arrhythmology
Verified
Journal Article
Open access
PDF file
LKL. E. Korobchenko
L. E. Korobchenko
TLT. A. Lyubimtseva
T. A. Lyubimtseva
KDKarapet Davtyan
Karapet Davtyan
ATA. G. Topchyan
A. G. Topchyan
GSG. Yu. Simonyan
G. Yu. Simonyan
ГСГ. Ю. Симонян
Г. Ю. Симонян
Aim. To study the characteristics of the atrial fibrillation (AF) cryoballoon ablation (CBA) procedure and features of patient’s management in real clinical practice in Russia.Methods. “Prospective Atrial Fibrillation Cryoablation Registry” is an observational prospective national multicenter study. It was conducted from 01.2017 to 12.2019 in centers of Russian Federation. The registry included patients over the age of 18 who were agreed to participate this study and had indications for CBA of AF. The study protocol did not provide for significant restrictions on inclusion criteria, procedure technique and postoperative follow-up. The data was collected prior to the CBA of AF, during hospitalization for CBA and on the 12-month follow-up.Results. Participating centers enroll 980 patients according to inclusion criteria. CBA of AF was performed in 976 (99.6%) (mean age 59.7±9.2 years, 545 (55.8%) men) primary procedure - 840 (86.1%), re-ablation - 136 (13.9%). Parox- ysmal AF occurred in 828 (84.8%) patients and persistent AF (mean time of persistence 4.4±3.7 months) - in 145 (15.1%) patients. The average procedure time was 108.1±33.3 minutes and mean fluoroscopy time was 24.9±13.6 min. Most of the procedures were performed under general anesthesia. Complications after AF CBA occurred in 53 (5.4%) patients. The most common complication was paresis of the phrenic nerve - 20 (37.7%) cases which were associated with lower temperatures of CBA application of the right pulmonary veins (τ=0.08; p<0.05). The features of antiarrhythmic and anticoagulant therapy were evaluated. A group of patients without adequate anticoagulant therapy in the postoperative period was identified. Due to COVID-19 restrictions only 374 (38.3%) patients completed 12-month follow-up. The recurrence of arrhythmia was occurred in 85 (22.7%) patients. Multivariate regression analysis revealed the following predictors of arrhythmia recurrence: the first procedure (OR 3.96; p=0.023), male sex (OR 1.77; p=0.014), duration of the procedure (min) (OR 1.01; p=0.007).Conclusion. CBA is an effective and relatively safe procedure for the treatment of paroxysmal and persistent AF. Data from real clinical practice show a low proportion of serious complications of AF CBA. Data on the dynamics of drug therapy, including anticoagulant and antiarrhythmic therapy, were obtained. The attention of specialists performing AF catheter ablation and patient monitoring is required, since errors in patient management have been identified.

12 October 2022 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
DMD. U. Malaev
D. U. Malaev
NGN. I. Grachev
N. I. Grachev
ДРД. А. Редькин
Д. А. Редькин
Highlights. Mechanical thrombectomy is the “gold standard” treatment of patients with large-vessel occlusions. Five randomized trials conducted in 2015 made a significant contribution to the development and introduction of mechanical thrombectomy into clinical practice. The DAWN and DEFUSE-3 trials have provided new insights into the pathophysiology of ischemic stroke and ensured the advancement in the therapeutic field.Abstract. Stroke is one of the leading causes of death and disability worldwide. The general strategy for the treatment of ischemic stroke is aimed at restoring blood flow to the ischemic regions of the brain. Intravenous thrombolysis has been the treatment for acute ischemic stroke since 1996. However, since 2015, as a result of 5 randomized trials, endovascular mechanical thrombectomy has become the gold standard for the treatment of patients with large cerebral artery occlusion. The DAWN and DEFUSE 3 trials have provided new insights into the pathophysiology of ischemic stroke, shifting the paradigm from “time = brain” to “collaterals = brain”. In this article, the authors will consider development of endovascular devices, modern mechanical thrombectomy techniques, and directions for further research of endovascular treatment for ischemic stroke.

15 June 2023 in Pacific Medical Journal
Verified
Journal Article
Open access
PDF file
NGN. I. Grachev
N. I. Grachev
VRV. G. Rapovka
V. G. Rapovka
The paper presents a clinical case of endovascular treatment for a patient affected by acute myocardial infarction combined with acute ischemic stroke. The study emphasizes a role of early diagnosis of ischemic stroke in timely detection of cerebral embolism in large vessels during the postoperative period. Treatment strategy is analyzed along with the effectiveness of intravascular thrombectomy that significantly reduces mortality and disability of patients with acute cerebrovascular disease.

14 August 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
EMEvgeny N Mikhaylov
Evgeny N Mikhaylov
TLT. A. Lyubimtseva
T. A. Lyubimtseva
KDKarapet Davtyan
Karapet Davtyan
ATA. G. Topchian
A. G. Topchian
ETE. S. Tarasyuk
E. S. Tarasyuk
DLDlebedev Lebedev
Dlebedev Lebedev
Aim. Current registry is the continued national study on cryoablation in atrial fibrillation (AF). The aim of the project is assessment of safety and efficacy of cryoballoon ablation of pulmonary veins from AF treatment in real clinical practice prospective observation.Material and methods. The project has been developed for prospective inclusion of the data to guarded automatic informational system, on clinical data of patients, ablation parameters, repeat ablation and results of 12-month follow-up. To participate in the project in January of 2017, the representatives of 33 in-patient facilities were invited, that routinely perform the procedure.Results. Twenty five institutions confirmed their participation, and by December of 2017, the database was completed by specialists from 13 clinics: information on the ablation procedure and outcomes is included for 451 patient. The enrollment is ongoing with estimated end by January 2019; prospective follow-up to be completed by January 2020.Conclusion. Prospective registry of AF cryoablation is important for gathering of experience and common analysis of the procedures throughout the country. Detailed analysis will make it to reveal predictors of efficacy and methods for procedural risk decrease.

29 June 2026 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
NGNikita I. Grachev
Nikita I. Grachev
YKYevgeny I. Kretov
Yevgeny I. Kretov
MLMark A/ Loskutnikov
Mark A/ Loskutnikov
ALAndrei L. Lukyanov
Andrei L. Lukyanov
DSDmitry Yu. Saiko
Dmitry Yu. Saiko
APAndrey V. Popov
Andrey V. Popov
Highlights For the first time in real-world clinical practice across several Russian regions, the high reproducibility and efficacy of the domestic Grasper stent-retriever for mechanical thrombectomy in stroke patients have been demonstrated. An unique routing ecosystem “UDAR” was developed, integrating the pre-hospital stage, “Tele-PVU” telemedicine support, and automated 5–7-minute express CT scan evaluation driven by artificial intelligence. The synergy of digital control and domestic medical devices enabled a 2.5-fold increase in mechanical thrombectomy volumes and reduced hospital mortality from ischemic stroke by 8.1%.   Aim . Analyze the results of the pilot project “UDAR” (Smile, Movement, Articulation, Solution) on reorganizing the routing of patients with acute cerebral blood circulation disorders (AHC) when using telemedicine in the territory of Primordia, to assess the effectiveness of modern methods of reperfusion using domestic stencil-reducers. Methods . The total number of patients suspected stroke included in the study was 18500. All patients at the pre-hospital stage were examined by a paramedic/ doctor of the emergency medical team, who entered on the tablet into the program “UDAR” patient data, then information was sent to the questionnaire of the program “UDAR” with automatic notification of the control center on the basis of a regional vascular center (RVC). The on-duty neurologist of the RVC then analyzed the data and gave recommendations for further routing to the primary vascular unit (PVU) or RVC (with LAMS > 3 points). If necessary, the neurologist of the RVC could conduct a telemedicine consultation with the medical doctor of the emergency medical team by video call to clarify the neurological status of the patient. Upon arrival of the patient in the PVU and CT-study of the brain, data was loaded into “UDAR” program. Control center radiologist had access to the patient’s CT scans. The first series of images was processed by artificial intelligence (AI) with identification of areas of detected pathologies, determination of the extent of lesions, scoring according to the ASPECTS scale prepared by an X-ray report. The second series was a native CT image. Based on the results of the examinations, the neurologist decided to leave the patient in the PVU or transfer to the RVC for mechanical thrombosis extraction. Results . During the lifetime of the project, there was an increase in the frequency of thrombolytic therapy (TLT) from 3.9% to 8.6% (by 4.6%), the number of mechanical thrombosis extractions increased by 1.5 times in 2022 compared to 2021 and 2.5 times in 2023 compared to 2021. Hospital mortality rates from ischaemic stroke in the Primorsky PVU have decreased from 21.7% in 2021 to 14.9% in 2022 and 13.6% in 2023. Conclusion . According to the data obtained from the pilot project, it was found that it is advisable to scale its results to other regions of the country.

19 July 2026 in Pacific Medical Journal
Verified
Journal Article
Open access
PDF file
NGN. I. Grachev
N. I. Grachev
VRV. G. Rapovka
V. G. Rapovka
EKE. A. Kovalyov
E. A. Kovalyov
EKE. I. Kretov
E. I. Kretov
НГН. И. Грачев
Н. И. Грачев
ЕКЕ. И. Кретов
Е. И. Кретов
Objective: To evaluate the efficacy and safety profile of the Grasper stent retriever, manufactured in Russia, in a preclinical model of large intracranial vessel occlusion. Furthermore, to determine the impact of clot phenotype and procedural burden on thrombectomy outcomes. Materials and methods . The study was conducted in vivo on 14 pigs, resulting in 41 episodes of occlusion. Three morphotypes of autologous clots were tested, including red, mixed, and white. Reperfusion was assessed using an adapted TICI (aTICI) scale. First pass effect (FPE) was defined as achieving aTICI 2c-3 after the first pass. Number of passes, puncture-to-reperfusion time, embolization to new territories (ENT), and angiographic vessel injury were analyzed. Results. FPE (aTICI 2c-3) was achieved in 51.2% of cases. Final successful reperfusion (aTICI 2b-3) was obtained in 100%, with aTICI 2c-3 in 92.7%. No perforations, contrast extravasation, or mortality occurred; dissections (4.9%) were associated with ≥ 4 passes. ENT was observed in 24.4% and was more frequent with ≥ 3 passes (40.0 vs 15.4%). Outcomes were clot-dependent: FPE reached 71.4% for red clots (mean 1.79 passes) versus 23.1% for white clots (3.31 passes; p < 0.05). Conclusion. The Grasper stent retriever demonstrated high recanalization efficacy with a favorable safety profile. Procedural burden is a key mediator of embolic and vascular complications. The clot phenotype influences the first pass effect and thus should be considered when selecting an initial thrombectomy strategy.